Literature DB >> 20810261

Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature.

John Robert Swiston1, Sindhu R Johnson, John T Granton.   

Abstract

RATIONALE: There is a lack of consensus on factors that predict mortality in idiopathic pulmonary arterial hypertension (IPAH). Tests that can accurately predict prognosis are needed to guide treatment and counsel patients.
METHODS: We conducted a systematic review to identify factors that prognosticate mortality in IPAH. Study design, cohort size, comparison method, measured value, and statistical significance was extracted for eight pre-selected parameters [pulmonary vascular resistance (PVR), mean pulmonary arterial pressure (mPAP), mean right atrial pressure (mRAP), cardiac output, right ventricular end diastolic pressure, functional class, 6 min walk distance (6MWD), and diffusing capacity of carbon monoxide].
RESULTS: 107 factors have been associated with mortality in IPAH. A reproducible predictive association with mortality was demonstrated for only 10 factors: functional class (14 studies), heart rate (10 studies), 6MWD (8 studies), pericardial effusion (5 studies), mPAP (10 studies), mRAP (17 studies), cardiac index (13 studies), stroke volume index (4 studies), PVR (10 studies), mixed venous PaO(2) or saturations (4 studies). Of the 8 factors chosen for detailed evaluation, there were at least half as many studies that evaluated the variable and did not find an association with mortality compared to those that did.
CONCLUSIONS: There is a large body of literature describing numerous factors that predict mortality in IPAH. Most factors have been assessed in very few studies. There are conflicting reports on the prognostic value of many factors. These discrepancies highlight the need to evaluate the literature in total when considering the utility of variables as prognostic factors in IPAH.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20810261     DOI: 10.1016/j.rmed.2010.08.003

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  31 in total

1.  Assessing response to therapy in idiopathic pulmonary arterial hypertension: a consensus survey of Canadian pulmonary hypertension physicians.

Authors:  Adrienne E Borrie; David N Ostrow; Robert D Levy; John R Swiston
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

2.  Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Authors:  Colm McCabe; Maxine Bennett; Natalie Doughty; Robert MacKenzie Ross; Linda Sharples; Joanna Pepke-Zaba
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

Review 3.  Hemodynamics should be the primary approach to diagnosing, following, and managing pulmonary arterial hypertension.

Authors:  Bradley A Maron
Journal:  Can J Cardiol       Date:  2014-09-28       Impact factor: 5.223

4.  Pericardial effusion in pulmonary arterial hypertension.

Authors:  Sandeep Sahay; Adriano R Tonelli
Journal:  Pulm Circ       Date:  2013-11-22       Impact factor: 3.017

5.  Value of impedance cardiography in patients studied for pulmonary hypertension.

Authors:  Adriano R Tonelli; Hassan Alnuaimat; Ning Li; Robin Carrie; Kamal K Mubarak
Journal:  Lung       Date:  2011-05-24       Impact factor: 2.584

6.  Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.

Authors:  Ghaleb Khirfan; Allaa Almoushref; Tawfeq Naal; Batool Abuhalimeh; Raed A Dweik; Gustavo A Heresi; Adriano R Tonelli
Journal:  Chest       Date:  2020-07-03       Impact factor: 9.410

7.  Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.

Authors:  Jason H Karnes; Howard W Wiener; Tae-Hwi Schwantes-An; Balaji Natarajan; Andrew J Sweatt; Abhishek Chaturvedi; Amit Arora; Ken Batai; Vineet Nair; Heidi E Steiner; Jason B Giles; Jeffrey Yu; Maryam Hosseini; Michael W Pauciulo; Katie A Lutz; Anna W Coleman; Jeremy Feldman; Rebecca Vanderpool; Haiyang Tang; Joe G N Garcia; Jason X-J Yuan; Rick Kittles; Vinicio de Jesus Perez; Roham T Zamanian; Franz Rischard; Hemant K Tiwari; William C Nichols; Raymond L Benza; Ankit A Desai
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

8.  Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study.

Authors:  Alexis L Beatty; Nelson B Schiller; Mary A Whooley
Journal:  Arch Intern Med       Date:  2012-07-23

9.  Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival.

Authors:  Avi Shimony; Benjamin D Fox; Jonathan Afilalo; Lawrence G Rudski; Andrew Hirsch; David Langleben
Journal:  Lung       Date:  2012-10-11       Impact factor: 2.584

10.  Prognostic factors in pulmonary hypertension.

Authors:  Flavia Catalina Corciova; Catalina Arsenescu-Georgescu
Journal:  Maedica (Buchar)       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.